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In the recent years, a wide range of metabonomic technologies are widely used in the modern research of traditional chinese
medicine (TCM). At present, the most prevailing methods for TCM research are mainly nuclear magnetic resonance (NMR), gas
chromatography-mass spectrometry (GC-MS), and liquid chromatography-mass spectrometry (LC-MS). With these techniques,
metabonomics will help to understand syndromes, eﬃcacy and toxicity of TCM. However, every analytical technique has its
advantages and drawbacks, and there exist some obstacles of its applications on TCM. So, we discuss metabonomics in TCM
and analyze some problems of its applications to study TCM in recent years. We believe that with the further development of
metabonomic analytical technology, especially multianalysed techniques, metabonomics will greatly promote TCM research and
be beneﬁcial to the modernization of TCM.
1.Introduction
TraditionalChineseMedicine(TCM)hasbeenusedinChina
for more than two thousand years in the prevention and
treatment of human diseases. Nowadays, due to the reliable
therapeutic eﬃcacy, TCM has become popular worldwide.
However, unique theory system, evident treatment eﬀective-
ness, and diﬃculty to analyze scientiﬁc deﬁnition hinder
the development of Traditional Chinese Medicine. Some
problems, such as poor quality control, complex active
ingredients, and unclear therapeutic mechanisms, still need
to be resolved. So, it is important to interpret TCM theory by
modern science and technology [1, 2].
Metabonomics is an emerging subject of the postgenome
era, which, together with genomics, transcriptomics and
proteomics, jointly constitutes the “Systems Biology” [3].
Metabonomics is concerned with the quantitative under-
standings of the metabolite component of integrated living
systems and its dynamic responses to the changes of both
endogenous and exogenous factors [4].
In the recent years, researches showed that the systematic
study of metabonomics is in agreement with TCM theory
in nature [5] .A sas y s t e m i ca p p r o a c h ,m e t a b o n o m i c s
adopts a “top-down” strategy to reﬂect the function of
organisms from terminal symptoms of metabolic network
and understand metabolic changes of a complete system
caused by interventions in a holistic context [6]. This
perfectly coincides with the holistic thinking of TCM [7, 8].
So, the international and domestic scholars have successively
studied the key scientiﬁc issues in TCM with metabonomic
technology,includingsyndrome,diﬀerentialtreatmentofthe
individual, synthetic eﬀect of Chinese medicine as a whole
in TCM, resources and quality control of Chinese Medicine.
These researches demonstrated that metabonomics plays an
increasingly important role in the study of TCM. Therefore,
this paper discusses some metabonomic applications on
TCM and analyses some obstacles of their applications on
TCM in recent years.
2. Applications of Metabonomics inTCM
2.1. Applications of Metabonomics in Theory of TCM. Re-
cently, a number of metabonomic technology have been
widely used in the modern research of TCM [9, 10].2 Evidence-Based Complementary and Alternative Medicine
These technologies included nuclear magnetic resonance
(NMR), LC-MS, and GC-MS, according to the major
detection methods used. For example, LC was usually
put into use on quality control of TCM and qualitative
and quantitative determination of active components in
TCM. NMR was often applied for biological ﬁngerprint
and elaboration of complicated TCM science theories, and
GC was constantly used for establishment of experimental
animal model, MS (often combined with other methods,
such as GC, LC) for assisting other analytical methods in
TCM modern research [11, 12]. The following are some
examples: Zhang et al. [13] applied HPLC-ESI time-of-ﬂight
mass spectrometry (HPLC-ESI-TOF-MS) in pharmacoki-
netics research for understanding TCM eﬃcacy. Ni et al.
[14] used LC-MS and GC-MS in TCM toxicity research.
Wei et al. [15] illustrated the high reliability of NMR-based
metabolomic approach on the study of the biochemical
eﬀects induced by traditional Chinese medicine. Therefore
we supposed that adopting the metabolomics technology
platform to study the complex theoretical system of TCM is
practicable.
2.2. Applications of Metabonomics in Syndrome of TCM.
There are speciﬁc metabolism patterns in diﬀerent physi-
ological and pathological stages according to the metabo-
nomics. The alteration of metabolism correlated closely with
physiology and pathology of entrails, which is diﬀerent from
single index and could reﬂect the concept of “symptoms” in
TCM better.
In recent years, applications of metabonomic technol-
ogy on syndrome of TCM have been widely reported.
Among these researches, Li et al. [16] found that con-
tents of formate, creatinine, 2-oxoglutarate, citrate, tau-
rine, trimethyl-amine-N-oxide, succinate, and hippurate
obviously changed between model and normal rats. So
these diﬀerential metabolites can be considered as potential
metabolic biomarkers of Qi deﬁciency and Blood Stasis
Syndrome. Luo et al. [17] studied the plasma metabolic
phenotype in rats with Syndrome of Liver Qi Stagnation
and spleen deﬁciency. Compared with control group, model
rats displayed signiﬁcant changes in spectral peak shapes
of acetate, lactate, tyrosine, low-density lipoprotein. These
altered metabolites can be used as biomarkers of Syndrome
of Liver Qi stagnation and Spleen deﬁciency.
Subsequently, metabonomics study showed that Kidney-
Yang Deﬁciency Syndrome is related to the disturbance
in energy metabolism, amino acid metabolism and gut
microﬂora. Xin-Blood Stasis Syndrome is related to the lipid
metabolism and glycol metabolism [18]. So, characteristic
metabolites identiﬁed by analysis of metabonomics could
study the essence of syndrome and therapeutic eﬀect mecha-
nism of TCM.
2.3. Applications of Metabonomics in Eﬃcacy of TCM. Chi-
nese medicine applys a multicomponents and multitargets
approach in the treatment of diseases, which is a perfect
match with the holistic concept of metabonomics [19,
20]. Recently, studies showed that metabonomics became
an increasingly important tool and has been successfully
used in evaluating the curative eﬀect and mechanism of
Chinese medicine. Among these researches, Gu et al. [21]
observed eﬀect of traditional Chinese medicine berberine
on type 1 diabetes based on metabomic method (UPLC
Q-TOF MS). These results suggested that berberine might
downregulate the high level of free fatty acids. Lu et al.
[22] investigated the metabolic eﬀects of total ginsenoside
(TG) on spontaneously hypertensive rat (SHR). In SHR rats,
the plasma levels of hexadecanoic acid, galactopyranoside,
octadecadienoic acid and butanoic acid were found as
special biomarker. Treated with TG, the metabolic proﬁles
of SHR become normal. Liu et al. [23] reported that Si
Jun Zi Decoction had eﬀects on increasing the mucous
protein in gastrointestinal cell, antagonizing acetylcholine,
andpromotingthesynthesisofhepaticglycogenandantioxi-
dation.Therefore,thesestudiesindicatedthatmetabonomics
as a systematic and holistic thinking could reveal com-
prehensive eﬃcacy of Chinese medicine and its complex
mechanism.
2.4. Metabonomics Research and Toxicity of TCM. Recently,
metabonomics provides the powerful technological method
for the study of the toxicity and safety evaluation of
Traditional Chinese Medicines. Among these researches,
Ma et al. [24] studied metabonomic characters of the
nephrotoxicity induced by Morning Glory Seed (MGS)
with UPLC-MS. These results revealed eight endogenous
metabolites as biomarkers for toxicology caused by MGS.
Sun et al. [25] analyzed bioﬂuids from rats treated with
Aconitum alkaloids which are the main toxic components
in Fu Zi using two metabonomic approaches. They found
higher levels of lactate, alanine, and lipids along with lower
levels of glucose, beta-hydroxybutyrate and creatine in the
plasma of the aconitine and mesaconitine groups than
those in the control group. Ni et al. [26] combined GC-
MS and LC-MS metabolic proﬁling approaches to unravel
the pathological outcomes of AA-induced nephrotoxicity.
This study revealed that AA led to direct cytotoxic eﬀect,
enzyme inhibition, the signiﬁcant alteration of gutmotivated
metabolites, and energy metabolism, and ultimately induced
a disruption of the kidney-related metabolic regulatory
network and renal function. So, many metabonomic-based
methods have been proved to facilitate TCM toxicity
investigation.
3. The Obstacles of Metabonomics in TCM
At present, more and more metabonomic technologies
have been used in TCM studies, such as nuclear magnetic
resonance (NMR), gas chromatography-mass spectrometry
(GC-MS), and liquid chromatography-mass spectrometry
(LC-MS). With these techniques, some desirable outcomes
have been gained in the studies of TCM, such as the target
organs assay, the establishment of pattern, the elucidation
of mechanism and the exploration of material foundation.
These results indicated that the development of metabo-
nomicsplaysacriticalroleinTCM.However,comprehensiveEvidence-Based Complementary and Alternative Medicine 3
analysisofmetabolomeandtheunequivocalidentiﬁcationof
the detected metabolite candidates are still a conundrum of
current chromatographic driven metabonomics studies. So,
currently using of metabonomics in TCM also encounters
many diﬃculties.
Based on the analysis of modern studies, we consider
that the main obstacles of metabonomics studies on TCM
over the past year are largely attributable to the following
reasons. Firstly, the existing analysis techniques failed to
analyze the full spectrum of metabolite and were lacking
of the quantitative analysis of metabonomics. There are
still more or less shortcomings and inadequacies in these
analytical techniques. Secondly, diﬃculty of the research lies
in too large amounts of data, and how to maximize using
data excavation technology is still the technical bottleneck
of metabonomics. Exogenous components of traditional
Chinese medicine in vivo are complicated, and the unknown
metabolite of these constituents from traditional Chinese
medicine in living organisms could have interference eﬀect.
It leads to increasing the diﬃculty to elucidate the metabolite
underlying biological signiﬁcance. Thirdly, it doesn’t attract
enough attention to combine proteomics, geonomics and
clinic data with metabonomics data, which lead to one-
sidedness results and fail in persuasiveness. And there is still
lack of analysis of the biomarker of TCM syndrome from
clinicalandbiologicalviewpoints.Lastly,thereisstillshortof
profoundawarenessofthegreatbeneﬁtsofmetabonomicsin
TCM and applications of TCM ﬁelds are still in its start-up
stage. Thus, we think, with these obstacles of metabonomics
application on TCM disposed, metabonomics will play more
and more important roles in TCM research, as well as in
deeper understanding of TCM.
4. Conclusions
Nowadays, as a new research method of the postgenome
era, metabonomics, which is characterized with endpoint
ampliﬁcation of the global biological and functional status,
is the best to ﬁt the holistic concept of TCM theory.
With metabonomic technology, we can not only interpret
the essence of TCM syndrome and the theory of “treat-
ment based on syndrome diﬀerentiation” but also elucidate
modern scientiﬁc connotation and toxicity of Chinese
medicine. However, quantitative evaluation of metabonomic
results, the eﬃcacy-based metabonomic comparison of mul-
ticomponents and multitargets herbal medicines with one-
component one-target drugs, still needs further study. We
consider that with the further development of metabonomic
analytical techniques, especially multi-analysed techniques,
metabonomics will greatly promote TCM research and be
beneﬁcial to the modernization of TCM.
Acknowledgment
This work was supported by the National Basic Research
Program of China (973 Program) (no. 2009CB522707) and
the National Natural Science Foundation of China (NSFC)
(no. 30901925).
References
[1] M. M. Zhou, Z. Q. Fan, W. Jia, and A. H. Zhao, “Integration
of the holistic concept of traditional medicine and the partial
characterofmodernmedicine—applicationsofmetabolomics
in traditional Chinese prescription’s research,” Chinese Journal
of Natural Medicines, vol. 7, no. 2, pp. 95–100, 2009.
[2] C. X. Liu, D. Y. Si, R. Z. Wan, Y. P. Lin, and Y. Y. Xu,
“Metabonomics in research of natural drugs and traditional
Chinese medicines,” Chinese Journal of Natural Medicines, vol.
6, no. 2, pp. 82–88, 2008.
[3] J. K. Nicholson and I. D. Wilson, “Understanding “global”
systems biology: metabonomics and the continuum of
metabolism,” Nature Reviews Drug Discovery, vol. 2, no. 8, pp.
668–676, 2003.
[4] H. R. Tang and Y. L. Wang, “Metabonomics: a revolution in
progress,” Progress in Biochemistry and Biophysics, vol. 33, no.
5, pp. 401–417, 2006.
[5] P. Li, L. P. Yang, and Y. W. Gong, “Application of systems biol-
ogy technology in research of traditional Chinese medicine,”
JournalofTraditionalChineseMedicine,vol.29,no.2,pp.153–
157, 2009.
[6] J. K. Nicholson, “Global systems biology, personalized
medicine and molecular epidemiology,” Molecular Systems
Biology, vol. 2, article 52, 2006.
[ 7 ]M .W a n g ,R .J .A .N .L a m e r s ,H .A .A .J .K o r t h o u te ta l . ,
“Metabolomics in the context of systems biology: bridging
Traditional Chinese Medicine and molecular pharmacology,”
Phytotherapy Research, vol. 19, no. 3, pp. 173–182, 2005.
[8] B. Wu, S. K. Yan, Z. Y. Shen, and W. D. Zhang, “Metabonomic
technique and prospect of its application in integrated tra-
ditional Chinese and Western medicine research,” Journal of
Chinese Integrative Medicine, vol. 5, no. 4, pp. 475–480, 2007.
[9] Y. Z. Liang, Y. Yu, Z. B. Yi, L. Z. Yi, W. Ping, and Y. L. Wang,
“Metabonomics and the modernization of traditional Chinese
medicine,” Acta Academiae Medicinae Sinicae, vol. 29, no. 6,
pp. 823–826, 2007.
[10] C. Zhu, P. Hu, Q. L. Liang, Y. M. Wang, and G. A. Luo,
“Integration of metabonomics technology and its application
in modernization of traditional Chinese medicine,” Acta
Pharmaceutica Sinica, vol. 43, no. 7, pp. 683–689, 2008.
[11] Y.M.Lao,J.G.Jiang,andL.Yan,“Applicationofmetabonomic
analytical techniques in the modernization and toxicology
research of traditional chinese medicine,” British Journal of
Pharmacology, vol. 157, no. 7, pp. 1128–1141, 2009.
[ 1 2 ]Y .H .L u ,H .P .H a o ,G .J .W a n g ,X .H .C h e n ,X .X .Z h u ,a n d
B. R. Xiang, “Metabolomics approach to the biochemical dif-
ferentiation of Traditional Chinese Medicine syndrome types
ofhypertension,”ChineseJournalofClinicalPharmacologyand
Therapeutics, vol. 12, no. 10, pp. 1144–1150, 2007.
[13] X. Zhang, L. W. Qi, L. Yi, P. Li, X. D. Wen, and Q. T. Yu,
“Screening and identiﬁcation of potential bioactive compo-
nents ina combined prescription ofDanggui Buxue decoction
using cell extraction coupled with high performance liquid
chromatography,” Biomedical Chromatography, vol. 22, no. 2,
pp. 157–163, 2008.
[14] Y.Ni,M.Su,Y.Qiuetal.,“Metabolicproﬁlingusingcombined
GC-MS and LC-MS provides a systems understanding of
aristolochic acid-induced nephrotoxicity in rat,” FEBS Letters,
vol. 581, no. 4, pp. 707–711, 2007.
[15] L. Wei, P. Liao, H. Wu et al., “Toxicological eﬀects of cinnabar
inratsbyNMR-basedmetabolicproﬁlingofurineandserum,”
Toxicology and Applied Pharmacology, vol. 227, no. 3, pp. 417–
429, 2008.4 Evidence-Based Complementary and Alternative Medicine
[ 1 6 ] L .L i ,J .N .W a n g,J .X .R e n ,J .F .X i a n g,Y .L .T a n g,a n dJ .X .L i u ,
“MetabonomicsstudyofurinefromratmodelofQi-diﬁciency
andBlood-stasissyndromeusingNMRspectroscopy,”Chinese
Science Bulletin, vol. 52, no. 15, pp. 1758–1762, 2007.
[17] H. G. Luo, J. Ding, G. X. Yue, and J. X. Chen, “Metabonomic
study of syndrome of liver qi stagnation and spleen deﬁciency
in rats,” Journal of Chinese Integrative Medicine, vol. 5, no. 3,
pp. 307–313, 2007.
[ 1 8 ] X .L u ,Z .X i o n g ,J .L i ,S .Z h e n g ,T .H u o ,a n dF .L i ,
“Metabonomic study on ’Kidney-Yang Deﬁciency syndrome’
and intervention eﬀects of Rhizoma Drynariae extracts in rats
using ultra performance liquid chromatography coupled with
mass spectrometry,” Talanta, vol. 83, no. 3, pp. 700–708, 2011.
[19] M. M. Zhou, W. Jia, and P. G. Xiao, “Systemic biologic study
on traditional Chinese medicine–a short-lived fad or a long-
term policy?” Chinese Journal of Integrative Medicine, vol. 28,
no. 9, pp. 773–778, 2008.
[20] S. S. Dou, R. H. Liu, P. Jiang, L. Liu, C. Zhang, G. A. Luo et
al., “System biology and its application in compound recipe
of traditional Chinese medicine study,” World Science and
Technology, vol. 10, no. 2, pp. 116–121, 2008.
[ 2 1 ]Y .G u ,Y .Z h a n g ,X .S h ie ta l . ,“ E ﬀect of traditional Chinese
medicine berberine on type 2 diabetes based on comprehen-
sivemetabonomics,”Talanta,vol.81,no.3,pp.766–772,2010.
[22] Y. H. Lu, G. J. Wang, Q. Huang et al., “Investigations into
metabonomic proﬁling of spontaneously hypertensive Rat
(SHR)andmetaboliceﬀectsoftotalginsenosideonSHRusing
GC/MS,”ChineseJournalofNaturalMedicines,vol.5,no .6,pp .
443–447, 2007.
[ 2 3 ]P .L i u ,Y .C .G e ,T .S .M a ,H .J .R e n ,Y .J .X u ,a n dD .M .X u ,
“Eﬀects of the extracts from Decoction for resuscitation and
its component herbs on PGI2, TXA2 and NO release from rat
vascular endothelial cells under hypoxia in vitro,” Zhongguo
Zhongyao Zazhi, vol. 29, no. 10, pp. 991–992, 2004.
[24] C. Ma, K. Bi, M. Zhang et al., “Metabonomic study of
biochemical changes in the urine of morning glory seed
treatedrat,”JournalofPharmaceuticalandBiomedicalAnalysis,
vol. 53, no. 3, pp. 559–566, 2010.
[25] B. Sun, L. Li, S. Wu et al., “Metabolomic analysis of bioﬂuids
from rats treated with Aconitum alkaloids using nuclear
magnetic resonance and gas chromatography/time-of-ﬂight
mass spectrometry,” Analytical Biochemistry, vol. 395, no. 2,
pp. 125–133, 2009.
[26] Y.Ni,M.Su,Y.Qiuetal.,“Metabolicproﬁlingusingcombined
GC-MS and LC-MS provides a systems understanding of
aristolochic acid-induced nephrotoxicity in rat,” FEBS Letters,
vol. 581, no. 4, pp. 707–711, 2007.